Arcutis Biotherapeutics Inc (ARQT)
8.36
-0.30
(-3.46%)
USD |
NASDAQ |
May 31, 16:00
8.35
-0.01
(-0.12%)
After-Hours: 20:00
Arcutis Biotherapeutics Accounts Payable (Quarterly): 12.97M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 12.97M |
December 31, 2023 | 11.99M |
September 30, 2023 | 13.18M |
June 30, 2023 | 17.16M |
March 31, 2023 | 12.48M |
December 31, 2022 | 8.827M |
September 30, 2022 | 8.666M |
June 30, 2022 | 8.437M |
March 31, 2022 | 12.47M |
December 31, 2021 | 7.353M |
Date | Value |
---|---|
September 30, 2021 | 4.871M |
June 30, 2021 | 2.676M |
March 31, 2021 | 3.146M |
December 31, 2020 | 7.14M |
September 30, 2020 | 5.039M |
June 30, 2020 | 8.253M |
March 31, 2020 | 4.759M |
December 31, 2019 | 1.405M |
September 30, 2019 | 3.159M |
December 31, 2018 | 1.801M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.405M
Minimum
Dec 2019
17.16M
Maximum
Jun 2023
8.104M
Average
8.253M
Median
Jun 2020
Accounts Payable (Quarterly) Benchmarks
Heron Therapeutics Inc | 0.837M |
Marinus Pharmaceuticals Inc | 6.125M |
Insmed Inc | 44.02M |
Agios Pharmaceuticals Inc | 11.16M |
AdaptHealth Corp | 226.42M |